1Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1 [J ]. AJNR, 2009, 30:19-30.
2Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2 [J ]. AJNR, 2009, 30: 232-252.
3Deistung A, Mentzel HJ, Rauscher A, et al. Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI) [ J ]. Z Med Phys, 2006, 16: 261-267.
4Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility- based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology [ J ]. AJNR, 2004, 25: 756- 760.
5Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI) [J]. Magn Reson Med, 2004, 52: 612-618.
6Sehgal V, Delproposto Z, Haddar D, et al. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses [J ]. J Magn Reson Imaging, 2006, 24: 41- 51.
9Park MJ, Kim HS, Jahng GH, et al. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhancedhigh-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with Mr perfusion imaging [J]. AJNR, 2009, 30: 1402-1408.
10Pinker K, Noebauer-Huhmann IM, Stavrou I, et al. High-resolution contrast-enhanced, susceptibility-weighted Mr imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings [ J ]. AJNR, 2007, 28: I280-1286.
4Liang L, Korogi Y, Sugahara T, et al. Detection of intraeranial hemorrhage with susceptibility-weighted MR sequences. AJNR, 1999,20 : 1527.
5Gomori JM, Grossman RI, Yu-Ip C, et al. NMR relaxation times of blood:dependence on field strength,oxidation state,and cell integrity. J Comput Assist Tomogr, 1987,11:684.
6Schenck JF. Magnetic resonance imaging of brain iron. J Neurol Sci, 2003,207:99.
7Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging,2005,22:439.
8Reichenbach JR, Venkatesan R, Schillinger DJ, et al. Small vessels in the Human brain:MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology, 1997,204:272.
9Yamada N, Imakita S, Sakuma T, et al. Intracranial calcification on gradient-echo phase image: depiction of diamagnetic susceptibility. Radiology, 1996,198 : 171.
10Lin W, Mukherjee P,An H, et al. hnproving high-resolution MR bold venographic imaging using a T1 reducing contrast agent. J Magn Reson Imaging, 1999, 10 : 118.
7Tang Y M,Ngai S,Stuckey S. The solitary enhancing cerebral le- sion:can FLAIR aid the differentiantion between glioma and me- tastasis[J]. AJNR,2006, 27(3):609-611.
8Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. Am J Neuroradiol, 2008, 29(3): 476-482.
9Robinson R J, Bhuta S. Susceptibility-weighted imaging of the brain: current utility and potential applications. J Neuroimaging, 2011, 21(4): e189-e204.
10Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol, 2007, 114(2): 97-109.
